PB9079
antibody from Boster Biological Technology
Targeting: CXCR3
CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9079 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-CXCR3 Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for CXCR3 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. CXCR3 information: Molecular Weight: 40660 MW; Subcellular Localization: Isoform 1: Cell membrane ; Multi-pass membrane protein ; Tissue Specificity: Isoform 1 and isoform 2 are mainly expressed in heart, kidney, liver and skeletal muscle. Isoform 1 is also expressed in placenta. Isoform 2 is expressed in endothelial cells. Expressed in T-cells (at protein level).
- Reactivity
- Human, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer.
CXCL10 and CXCR3 in the Trigeminal Ganglion Contribute to Trigeminal Neuropathic Pain in Mice.
CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways.
CXCL10/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice.
Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.
Wei W, Ye B, Huang Z, Mu X, Qiao J, Zhao P, Jiang Y, Wu J, Zhan X
Cancers 2023 Jul 19;15(14)
Cancers 2023 Jul 19;15(14)
CXCL10 and CXCR3 in the Trigeminal Ganglion Contribute to Trigeminal Neuropathic Pain in Mice.
Ju YY, Jiang M, Xu F, Wang D, Ding B, Ma LJ, Wu H
Journal of pain research 2021;14:41-51
Journal of pain research 2021;14:41-51
CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways.
Chen X, He H, Xiao Y, Hasim A, Yuan J, Ye M, Li X, Hao Y, Guo X
Frontiers in oncology 2021;11:629350
Frontiers in oncology 2021;11:629350
CXCL10/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice.
Kong YF, Sha WL, Wu XB, Zhao LX, Ma LJ, Gao YJ
Neuroscience bulletin 2021 Mar;37(3):339-352
Neuroscience bulletin 2021 Mar;37(3):339-352
Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q, Sun J, Cao Y, Liu B, Li L, Mohammadtursun N, Zhang H, Dong J, Wu J
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Mar;123:109735
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Mar;123:109735
An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.
Ding Q, Xia Y, Ding S, Lu P, Sun L, Liu M
Oncotarget 2016 Mar 22;7(12):14405-14
Oncotarget 2016 Mar 22;7(12):14405-14
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Anti-CXCR3 Picoband antibody, PB9079-1.JPGIHC(P): Rat Kidney Tissue
- Additional image